focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksALM.L Regulatory News (ALM)

  • There is currently no data for ALM

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Changes

10 Mar 2020 07:00

RNS Number : 5157F
Allied Minds PLC
10 March 2020
 

10 March 2020

 

Allied Minds

 

Directorate changes

 

Allied Minds plc (LSE: ALM), the IP commercialisation company focused on early stage company development within the technology sector, has appointed Harry Rein, currently Senior Independent Director, as Chairman. He succeeds Jeff Rohr, who has stepped down. Additionally, Bruce Failing has been appointed as Non-Executive Director. Both appointments are with immediate effect.

 

Bruce has over 30 years of management and investment experience in the areas of media and consumer products, applied technology and logistics management. He founded and currently is the General Partner of Alerion Partners. Previously, he was CEO of Productivity Solutions, Electronic Retailing Systems and Actmedia, and Executive Chairman of ScentAir Technologies and Lamaze Publishing & the Newborn Channel. Bruce attended Tufts University (1971) and holds an MBA from Harvard Business School (1973).

 

Bruce will assume the Senior Independent Director role, Chair the Remuneration Committee and be on the Nomination and Audit Committees.

 

Mark Lerdal will Chair the Audit Committee. Harry will Chair the Nomination Committee.

 

Harry Rein, Non-Executive Chairman, commented:

 

"On behalf of the Board, I extend our deepest thanks and appreciation to Jeff for his many dedicated years of service on the Board and the leadership and support he has provided over the past six years. 

 

"I welcome Bruce to the Board. His operational and management experience and expertise is invaluable and positions him perfectly to help us.

 

"I look forward to becoming Chairman and continuing to work closely with my fellow directors as we execute on our strategy of delivering shareholder value by focusing on our existing portfolio."

 

There are no further details in relation to Mr. Failing's appointment which require disclosure pursuant to Listing Rule 9.6.13.

 

For more information, please contact:

 

Allied Minds plc

+1 617 419 1800

IR@alliedminds.com

Instinctif

+44 20 7457 2020

Adrian Duffield / Chantal Woolcock

 

About Allied Minds

Allied Minds plc is an IP commercialisation company focused on early stage company development within the technology sector. With origination relationships that span US federal laboratories, universities, and leading US corporations, Allied Minds historically created, and now operates and funds, a portfolio of companies to generate long-term value for its investors and stakeholders. Based in Boston, Allied Minds supports its businesses with capital, management, expertise and shared services. For more information, please visit www.alliedminds.com.

 

Allied Minds Forward-Looking Statement

This press release contains statements that are or may be forward-looking statements, including statements that relate to Allied Minds' future prospects, developments and strategies. The forward-looking statements are based on current expectations and are subject to known and unknown risks and uncertainties that could cause actual results, performance and achievements to differ materially from current expectations, including, but not limited to, those risks and uncertainties described in the risk factors included in Allied Minds' regulatory filings. These forward-looking statements are based on assumptions regarding the present and future business strategies of Allied Minds and the environment in which it will operate in the future. Each forward-looking statement speaks only as at the date of this press release. Except as required by law, regulatory requirement, the Listing Rules and the Disclosure Guidance and Transparency Rules, neither Allied Minds nor any other party intends to update or revise these forward-looking statements, whether as a result of new information, future events or otherwise.

 

This announcement contains inside information as defined in Article 7 of the Market Abuse Regulation No. 596/2014.

 

###

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOAUKOKRRSUORAR
Date   Source Headline
28th Jan 20224:36 pmRNSPrice Monitoring Extension
26th Jan 20224:41 pmRNSSecond Price Monitoring Extn
26th Jan 20224:36 pmRNSPrice Monitoring Extension
7th Dec 20214:41 pmRNSSecond Price Monitoring Extn
7th Dec 20214:36 pmRNSPrice Monitoring Extension
6th Dec 20214:41 pmRNSSecond Price Monitoring Extn
6th Dec 20214:36 pmRNSPrice Monitoring Extension
24th Nov 20214:40 pmRNSSecond Price Monitoring Extn
24th Nov 20214:35 pmRNSPrice Monitoring Extension
8th Nov 20217:00 amRNSPortfolio company update
1st Nov 20217:00 amRNSDisposal of portfolio company
27th Oct 20214:36 pmRNSPrice Monitoring Extension
22nd Oct 20214:35 pmRNSPrice Monitoring Extension
6th Oct 20217:00 amRNSHalf-year Report
28th Sep 20214:41 pmRNSSecond Price Monitoring Extn
28th Sep 20214:37 pmRNSPrice Monitoring Extension
27th Sep 20214:41 pmRNSSecond Price Monitoring Extn
27th Sep 20214:36 pmRNSPrice Monitoring Extension
23rd Sep 20214:41 pmRNSSecond Price Monitoring Extn
23rd Sep 20214:36 pmRNSPrice Monitoring Extension
23rd Sep 20217:00 amRNSNotice of Results - Update
8th Sep 20214:40 pmRNSSecond Price Monitoring Extn
8th Sep 20214:36 pmRNSPrice Monitoring Extension
8th Sep 20217:00 amRNSNotice of Results
1st Sep 20211:07 pmRNSTotal Voting Rights
25th Aug 20214:41 pmRNSSecond Price Monitoring Extn
25th Aug 20214:35 pmRNSPrice Monitoring Extension
23rd Aug 20214:41 pmRNSSecond Price Monitoring Extn
23rd Aug 20214:36 pmRNSPrice Monitoring Extension
19th Aug 202110:10 amRNSDirector/PDMR Shareholding
19th Aug 202110:09 amRNSDirector/PDMR Shareholding
19th Aug 202110:07 amRNSDirector/PDMR Shareholding
11th Aug 20217:00 amRNSUpdate on portfolio companies
11th Aug 20217:00 amRNSTransaction in Own Shares
9th Aug 20217:00 amRNSTransaction in Own Shares
6th Aug 20217:00 amRNSTransaction in Own Shares
4th Aug 20217:00 amRNSTransaction in Own Shares
3rd Aug 20217:00 amRNSTransaction in Own Shares
2nd Aug 20213:31 pmRNSTotal Voting Rights
2nd Aug 20217:00 amRNSTransaction in Own Shares
30th Jul 20217:00 amRNSTransaction in Own Shares
29th Jul 20217:00 amRNSTransaction in Own Shares
28th Jul 20217:00 amRNSTransaction in Own Shares
27th Jul 20217:00 amRNSTransaction in Own Shares
23rd Jul 20217:00 amRNSTransaction in Own Shares
22nd Jul 20217:00 amRNSTransaction in Own Shares
21st Jul 20217:00 amRNSTransaction in Own Shares
20th Jul 20214:41 pmRNSHolding(s) in Company
20th Jul 20217:00 amRNSTransaction in Own Shares
19th Jul 20217:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.